John E. Dick
- Hematology top 0.01%
- Hematopoietic Stem Cell Transplantation 81
- Acute Myeloid Leukemia Research 75
- Oncology top 0.02%
- Cancer Cells and Metastasis 23
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 24
- Genetics top 0.05%
- Virus-based gene therapy research 35
- Mesenchymal stem cell research 23
- Immunology top 0.1%
- Immune Cell Function and Interaction 47
- T-cell and B-cell Immunology 26
- Co-authors
- Dominique BonnetAntonija KresoCatherine O′BrienJean WangSteven GallingerAaron PollettBarbara MurdochTsvee Lapidot
- Cited by
- HematologyOncologyCancer Research
- Partner nations
- CanadaUnited StatesIsrael
In The Last Decade
John E. Dick
257 papers receiving 40.0k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Hematology 12.0k
- Oncology 17.4k
- Cancer Research 7.3k
- Genetics 5.1k
- Immunology 8.4k
Countries citing papers authored by John E. Dick
This map shows the geographic impact of John E. Dick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Dick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Dick more than expected).
Fields of papers citing papers by John E. Dick
This network shows the impact of papers produced by John E. Dick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Dick. The network helps show where John E. Dick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John E. Dick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 8 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 11 | |
| 6 | 2022 | 3 | |
| 7 | 2019 | 6 | |
| 8 | 2019 | 10 | |
| 9 | 2019 | 0 | |
| 10 | 2017 | 80 | |
| 11 | 2017 | 19 | |
| 12 | 2017 | 2 | |
| 13 | 2016 | 15 | |
| 14 | Distinct routes of lineage development reshape the human blood hierarchy across ontogenybreakdown → | 2015 | 493 |
| 15 | Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancerbreakdown → | 2012 | 557 |
| 16 | 2011 | 37 | |
| 17 | 2008 | 36 | |
| 18 | Anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in pancreatic and breast cancer models and recognizes CD9 on CD34+CD38- leukemic cancer stem cells. | 2008 | 2 |
| 19 | 2005 | 26 | |
| 20 | 1993 | 4 |
About John E. Dick
John E. Dick is a scholar working on Hematology, Genetics and Immunology, having authored 266 papers that have together received 40.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (81 papers), Acute Myeloid Leukemia Research (75 papers), Immune Cell Function and Interaction (47 papers), Virus-based gene therapy research (35 papers), T-cell and B-cell Immunology (26 papers), Cancer Genomics and Diagnostics (24 papers), Cancer Cells and Metastasis (23 papers) and Mesenchymal stem cell research (23 papers). The work is most often cited by research in Hematology (12.0k citations), Oncology (17.4k citations) and Cancer Research (7.3k citations). John E. Dick has collaborated with scholars based in Canada, United States and Israel. Frequent co-authors include Dominique Bonnet, Antonija Kreso, Catherine O′Brien, Jean Wang, Steven Gallinger, Aaron Pollett, Barbara Murdoch, Tsvee Lapidot, Olga I. Gan and Liqing Jin. Their work appears in journals such as Blood, Experimental Hematology, Nature Medicine, Proceedings of the National Academy of Sciences and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.